Drug-resistant Streptococcus pneumoniae: rational antibiotic choices
- 1 May 1999
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 106 (5) , 19-25
- https://doi.org/10.1016/s0002-9343(98)00351-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Low Dosage and Long Treatment Duration of β-LactamJAMA, 1998
- THE CLINICAL IMPACT OF RESISTANCE IN THE MANAGEMENT OF PNEUMOCOCCAL DISEASEInfectious Disease Clinics of North America, 1997
- Antibiotic Prescribing for Adults With Colds, Upper Respiratory Tract Infections, and Bronchitis by Ambulatory Care PhysiciansJAMA, 1997
- Parental Issues in Selection of Antimicrobial Agents for Infants and ChildrenClinical Pediatrics, 1997
- Epidemiology and prevention of pneumococcal infectionsCurrent Opinion in Pediatrics, 1997
- Effect of Antimicrobial Use and Other Risk Factors on Antimicrobial Resistance in PneumococciMicrobial Drug Resistance, 1997
- Antimicrobial-Drug ResistanceNew England Journal of Medicine, 1996
- The Continued Emergence of Drug-Resistant Streptococcus pneumoniae in the United States: An Update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance SystemThe Journal of Infectious Diseases, 1996
- Minimizing the Impact of Drug-Resistant Streptococcus pneumoniae (DRSP)Published by American Medical Association (AMA) ,1996
- Emerging Resistance to Antimicrobial Agents in Gram-Positive BacteriaDrugs, 1996